157 related articles for article (PubMed ID: 33752525)
21. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
22. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
23. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
Jiao Y; Li Y; Ji B; Cai H; Liu Y
J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
[TBL] [Abstract][Full Text] [Related]
24. The expression of MYC is strongly dependent on the circular PVT1 expression in pure Gleason pattern 4 of prostatic cancer.
Umemori M; Kurata M; Yamamoto A; Yamamoto K; Ishibashi S; Ikeda M; Tashiro K; Kimura T; Sato S; Takahashi H; Kitagawa M
Med Mol Morphol; 2020 Sep; 53(3):156-167. PubMed ID: 31932969
[TBL] [Abstract][Full Text] [Related]
25. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
26. Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients.
Bai J; Huang G
Medicine (Baltimore); 2020 May; 99(22):e20204. PubMed ID: 32481386
[TBL] [Abstract][Full Text] [Related]
27. Interactions of
Lin HY; Callan CY; Fang Z; Tung HY; Park JY
Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1067-1075. PubMed ID: 30914434
[TBL] [Abstract][Full Text] [Related]
28. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
[TBL] [Abstract][Full Text] [Related]
29. Five lncRNAs Associated With Prostate Cancer Prognosis Identified by Coexpression Network Analysis.
Gong X; Ning B
Technol Cancer Res Treat; 2020; 19():1533033820963578. PubMed ID: 33084528
[TBL] [Abstract][Full Text] [Related]
30. A four-gene signature associated with clinical features can better predict prognosis in prostate cancer.
Yuan P; Ling L; Fan Q; Gao X; Sun T; Miao J; Yuan X; Liu J; Liu B
Cancer Med; 2020 Nov; 9(21):8202-8215. PubMed ID: 32924329
[TBL] [Abstract][Full Text] [Related]
31. The effects of LncRNA PVT1 on clinical characteristics and survival in breast cancer patients: A protocol for systematic review and meta analysis.
Xie L; Feng G; Zhu P; Xie J
Medicine (Baltimore); 2021 Feb; 100(8):e24774. PubMed ID: 33663093
[TBL] [Abstract][Full Text] [Related]
32. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer.
Xia Q; Li J; Yang Z; Zhang D; Tian J; Gu B
Medicine (Baltimore); 2020 Feb; 99(7):e18993. PubMed ID: 32049793
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNA PVT1 as a Potent Predictor of Prognosis in Cancers: a Meta-Analysis.
Pan X; Li B; Fan N; Li J; Cai F; Zhao G; Zheng G; Gao C
Clin Lab; 2017 Oct; 63(10):1657-1666. PubMed ID: 29035442
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of circ_PVT1 and circ_001569 Indicate Unfavorable Prognosis in Colorectal Cancer.
Mai S; Zhang Z; Mi W
Ann Clin Lab Sci; 2021 Jan; 51(1):55-60. PubMed ID: 33653781
[TBL] [Abstract][Full Text] [Related]
37. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a.
Liu HT; Fang L; Cheng YX; Sun Q
Cancer Med; 2016 Dec; 5(12):3512-3519. PubMed ID: 27794184
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
[TBL] [Abstract][Full Text] [Related]
39. High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma.
Xu H; Gong J; Liu H
PLoS One; 2017; 12(12):e0189675. PubMed ID: 29244840
[TBL] [Abstract][Full Text] [Related]
40. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
Gong W; Tian M; Qiu H; Yang Z
Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
